A UK taskforce has voiced concerns that an early coronavirus vaccine "is likely to be imperfect" and that they "might not work for everyone". According to a piece published in The Lancet medical journal, Kate Bingham, UK Vaccine Taskforce Chair said ''we do not know that we will ever have a vaccine at all.

First generation of coronavirus vaccine 'likely to be imperfect', says UK taskforce

Union Minister Pratap Sarangi on Sunday said that all people of the country will be given free COVID vaccine, amidst the demand by opposition parties in the country for it and not only in poll-bound Bihar as announced by the BJP.

All citizens in India to get free COVID-19 vaccine: Union Minister Pratap Sarangi

Several countries are now engaged in initiatives aimed at working with vaccine manufacturers to provide countries worldwide equitable access to safe and effective vaccines.

Gravitas: Coronavirus exit strategy depends on getting vaccine to whole world

A study claimed vaccines can take an average of 10 years to develop. But scientists may come up with a vaccine for the Wuhan Coronavirus in less than a year. Fast-tracking a vaccine has also raised the risks. WION's Palki Sharma tells you why the urgency could compromise the process.

Gravitas: Hunt for a vaccine, The hefty cost for cutting corners

The University of Oxford's Brazilian trial of its vaccine candidate will continue after the death of a volunteer, the university said on Wednesday, adding an independent review had revealed no safety concerns.

Oxford's Brazil vaccine trial to continue even after volunteer's death

Brazil's President Jair Bolsonaro and a high-ranking health official said on Wednesday the federal government will not buy a COVID-19 vaccine from China's Sinovac, one day after the Health Minister said it would be included in the nation's immunization program.

Bolsonaro drops plans to buy Chinese vaccine: Says, 'Its expensive and unscientific'

Five people have died after getting flu shots in South Korea in the past week, authorities said, raising concerns over the vaccine's safety just as the seasonal inoculation programme is expanded to head off potential COVID-19 complications.

Five South Koreans die after getting flu shots, sparking vaccine fears

Scientists at Imperial College London plan to deliberately infect volunteers with the coronavirus early next year, launching the world’s first effort to study how vaccinated people respond to being intentionally exposed to the virus and opening up a new, uncertain path to identifying an effective vaccine.

To test virus vaccines, UK study will intentionally infect volunteers

China's state-run company Sinopharm is offering free COVID-19 vaccine to students going abroad for higher studies. Sinopharm is Group Co Ltd is currently developing two coronavirus vaccines.

Chinese company Sinopharm offering free COVID-19 vaccine to students

Amid growing concern over access to Covid-19 medical products, Moderna has decided not to enforce its patent rights related to its experimental vaccine. Watch report.

Moderna vows not to enforce Covid-19 patents: WHO welcomes move

An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.

Dr Reddy's asked to reapply for phase two, three clinical trials of Russian COVID-19 vaccine

India has assured Myanmar it would give the country priority on coronavirus vaccine and speed up infrastructure projects in the country during the visit of Army Chief General MM Naravane and Foreign Secretary Harsh Vardhan Shringla's two-day visit.

India assures Myanmar on COVID-19 vaccine, speeding up infra projects

Russia expects to register a second potential vaccine against COVID-19 by October 15. Vaccine has been named as 'Epivaccorona'.

COVID-19: Russia completes clinical trials of second vaccine

Serum Institute of India will make up to 200 million COVID-19 vaccine doses for poorer countries, including India, next year, as the Bill & Melinda Gates Foundation and GAVI vaccines alliance have doubled their funding, the company said on Tuesday.

Serum Institute of India to boost production of COVID-19 vaccine doses to 200 million

A Chinese developed Coronavirus vaccine could be ready for public use by the end of this year. Watch the report to know more

China developed Coronavirus vaccine could get nod this year

American life finds itself in the middle of a plague that answers to no calendar, ideology or political objective. Just weeks away from the #USElection, the arrival of a vaccine takes the centre stage in American politics.

Vaccine: A guarantee to election success?

Wealthy nations that have just 13 per cent of the global population have already bought half of the potential drugs that are leading the Covid-19 vaccines race, a report by Oxfam claimed.

Rich nations with 13% population signed deals for getting over half of Covid-19 vaccines: Study

The United Arab Emirates on Monday granted emergency approval for use of a coronavirus vaccine, six weeks after human trials in the Gulf Arab state started. A phase III trial of a COVID-19 inactivated vaccine developed by Chinese state-owned pharmaceutical company Sinopham began in the UAE in July and is yet to be completed.

UAE announces emergency approval for use of COVID-19 vaccine

Around 50,000 people, across several countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group

Tracking COVID-19 vaccine: China's phase 3 vaccine proceedings going smooth

In a big blow to the expectations regarding the covid-19 vaccine, the Serum Institute of India has said adequate coronavirus vaccine will not be available for everybody in the world to be immunised until the end of 2024.

Coronavirus vaccine won’t be available to everyone before 2024 end: India's Serum Institute chief

US drugmaker Pfizer's chief Albert Bourla on Sunday said it is ''likely'' the coronavirus vaccine will be deployed to all Americans by the end of this year. Pfizer and its partner BioNTech hope to wrap up final-stage Phase III trials of their Covid-19 vaccine candidate as early as next month.

Americans can get COVID-19 vaccine before year-end, says Pfizer CEO

Pharmaceuticals giant AstraZeneca on Tuesday said that it had to "voluntarily paused" a randomized clinical trial of its coronavirus vaccine. The company called it a routine action after a volunteer developed an unexplained illness.

AstraZeneca 'voluntarily pauses' clinical trials for Oxford's COVID-19 vaccine after unexplained illness

Around 50,000 people, across a number of countries, are participating in phase 3 clinical trials of a COVID vaccine developed by the China National Biotec Group (CNBG), the company said on Saturday in a press release.

50,000 people globally part of phase 3 trial of Chinese covid-19 vaccine 

covid-19-vaccine

Covid 19 Vaccine, News on Covid 19 Vaccine, stories on Covid 19 Vaccine, articles on Covid 19 Vaccine, Covid 19 Vaccine stories at Wion, Covid 19 Vaccine news, Covid 19 Vaccine latest news

covid 19-vaccine

First generation of coronavirus vaccine 'likely to be imperfect', says UK taskforce

All citizens in India to get free COVID-19 vaccine: Union Minister Pratap Sarangi

Gravitas: Coronavirus exit strategy depends on getting vaccine to whole world

Gravitas: Hunt for a vaccine, The hefty cost for cutting corners

Oxford's Brazil vaccine trial to continue even after volunteer's death

Bolsonaro drops plans to buy Chinese vaccine: Says, 'Its expensive and unscientific'

Five South Koreans die after getting flu shots, sparking vaccine fears

To test virus vaccines, UK study will intentionally infect volunteers

Chinese company Sinopharm offering free COVID-19 vaccine to students

Moderna vows not to enforce Covid-19 patents: WHO welcomes move

Dr Reddy's asked to reapply for phase two, three clinical trials of Russian COVID-19 vaccine

India assures Myanmar on COVID-19 vaccine, speeding up infra projects

COVID-19: Russia completes clinical trials of second vaccine

Serum Institute of India to boost production of COVID-19 vaccine doses to 200 million

China developed Coronavirus vaccine could get nod this year

Vaccine: A guarantee to election success?

Vaccine: A guarantee to election success?

Rich nations with 13% population signed deals for getting over half of Covid-19 vaccines: Study

UAE announces emergency approval for use of COVID-19 vaccine

Tracking COVID-19 vaccine: China's phase 3 vaccine proceedings going smooth

Coronavirus vaccine won’t be available to everyone before 2024 end: India's Serum Institute chief

Americans can get COVID-19 vaccine before year-end, says Pfizer CEO

AstraZeneca 'voluntarily pauses' clinical trials for Oxford's COVID-19 vaccine after unexplained illness

50,000 people globally part of phase 3 trial of Chinese covid-19 vaccine